Speaker Profile
Biography
Shaun Wootten is a PhD candidate at Arizona State University specializing in complex in-vitro systems, particularly Organ-on-a-Chip platforms, to advance oncology drug screening within the Nikkhah Lab. His work focuses on developing high-throughput methods to test cancer therapies, aiming to enhance precision medicine while reducing reliance on animal models. Through biomimetic technologies, the potential for ethical and more effective pharmaceutical development is possible.
Talk
Tumor On-a-Chip Technology: Advancing Cancer Discoveries
This presentation highlights the use of Tumor-on-a-Chip technology to model oncology tumor microenvironments, offering a dynamic platform for studying tumor growth, stromal interactions, and drug responses. By mimicking physiological conditions, this system provides deeper insights into cancer biology and serves as a powerful tool for advancing personalized therapies and drug development.
Clinical & Research Tools Showcase:
Arizona State University
The Nikkhah Lab at ASU integrates biomaterials, stem cells, and micro/nanotechnologies to create vascularized tissue models and study cancer metastasis. By examining tumor microenvironments, it drives innovation in personalized medicine, regenerative therapies, and global biomedical challenges through cutting-edge, interdisciplinary research.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 Clinical & Research Tools Showcase will provide a 15-30 minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.